Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$94.61 +0.19 (+0.20%)
At close: Nov 11, 2026 · 4:00 PM EST

Mirum Pharmaceuticals (MIRM) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

Mirum Pharmaceuticals (MIRM) posted Return on Capital Employed [ROCE] of -119.08% for Q3 2026, down 112.05 percentage points from -7.02% a year earlier and down 7.16 percentage points from the prior quarter.

Analysis

Mirum Pharmaceuticals (MIRM) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025, Mirum Pharmaceuticals' Return on Capital Employed [ROCE] came in at -4.02%, up 12.45 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has increased for four consecutive years, with a five-year change of +55.47 percentage points (FY2020 to FY2025).
  • In prior years, Mirum Pharmaceuticals' Return on Capital Employed [ROCE] was -16.46% in FY2024 (+9.99 pp), -26.45% in FY2023 (+24.21 pp), -50.65% in FY2022 (+26.36 pp) and -77.02% in FY2021 (-17.53 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -134.07% in Q1 2026 to a high of -3.64% in Q4 2025 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last three quarters, with an average year-over-year change of -36.48 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2022, with a gain of 35.21 percentage points; the weakest was Q1 2026, with a drop of 120.26 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -111.92% (Q2 2026), -134.07% (Q1 2026) and -3.64% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Mirum Pharmaceuticals 6.16 Bn 4.58 Bn 150.55 Mn -119.08%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -119.08%
Jun 30, 2026 -111.92%
Mar 31, 2026 -134.07%
Dec 31, 2025 -3.64%
Sep 30, 2025 -7.02%
Jun 30, 2025 -10.13%
Mar 31, 2025 -13.80%
Dec 31, 2024 -16.14%
Sep 30, 2024 -17.49%
Jun 30, 2024 -19.93%
Mar 31, 2024 -19.96%
Dec 31, 2023 -19.44%
Sep 30, 2023 -23.44%
Jun 30, 2023 -35.86%
Mar 31, 2023 -42.68%
Dec 31, 2022 -44.65%
Sep 30, 2022 -51.05%
Jun 30, 2022 -62.91%
Mar 31, 2022 -62.95%
Dec 31, 2021 -78.00%
API Access

Mirum Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MIRM&period=max&api_key=YOUR_API_KEY